TrialBMC medicine2022

Ezetimibe combination therapy with statin for non-alcoholic fatty liver disease: an open-label randomized controlled trial (ESSENTIAL study).

Yongin Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.